NLRP3 and hypertensive disorder: In the mice with hypertension, MCC950 has been observed to reduce the expression of NLRP3 inflammasome subunits and markers of inflammation, and kidney injury, suggesting that MCC950’s ability to lower blood pressure in salt-induced hypertension is mediated through the suppression of inflammasome activity (137, 138).